IGM Biosciences to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

IGM Biosciences, a clinical-stage biotechnology firm, announced that CEO Fred Schwarzer participated in a fireside chat ahead of the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1-3, 2020. A recording of this discussion is accessible on the company’s website in the Investors section and will be available for 90 days. IGM Biosciences focuses on developing engineered IgM antibodies and has made significant advancements since 2010 in overcoming challenges related to their therapeutic use.

MOUNTAIN VIEW, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, has participated in a fireside chat in advance of the Piper Sandler 32^nd Annual Virtual Healthcare Conference, being held December 1-3, 2020.

A recording of the fireside chat is now available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations and will be available for 90 days.

About IGM Biosciences, Inc.
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.

Contact:

Argot Partners
David Pitts
212-600-1902
igmbio@argotpartners.com

FAQ

What is the significance of IGM Biosciences' participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference?

IGM Biosciences' participation highlights its ongoing efforts to communicate advancements in engineered IgM antibodies, crucial for attracting investor interest.

Where can I find the recording of the fireside chat by IGM Biosciences CEO?

The recording is available on the 'Events and Presentations' page in the Investors section of IGM Biosciences’ website.

What is the focus of IGM Biosciences as a biotechnology company?

IGM Biosciences specializes in creating and developing engineered IgM antibodies, aiming to leverage their unique properties for therapeutic purposes.

When was the fireside chat with IGM Biosciences CEO held?

The fireside chat was conducted in advance of the Piper Sandler 32nd Annual Virtual Healthcare Conference, scheduled for December 1-3, 2020.

How long will the fireside chat recording be available to access?

The recording of the fireside chat will be available for 90 days on the company’s website.